Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Zai Lab Ltd | Director | American Depositary Shares | 383K | $8.17M | $21.33 | Jun 18, 2024 | Direct |
Syros Pharmaceuticals, Inc. | Director | Common Stock | 16K | $79.2K | $4.95 | Jun 5, 2024 | Direct |
Syros Pharmaceuticals, Inc. | Director | Stock Option (right to buy) | 6K | Jun 5, 2024 | Direct | ||
Forma Therapeutics Holdings, Inc. | Director | Common Stock | 0 | $5.05 | Oct 14, 2022 | Direct | |
Forma Therapeutics Holdings, Inc. | Director | Stock Option (Right to Buy) | 0 | Oct 14, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ZLAB | Zai Lab Ltd | Jun 18, 2024 | 1 | $0 | 4 | Jun 20, 2024 | Director |
SYRS | Syros Pharmaceuticals, Inc. | Jun 5, 2024 | 2 | $0 | 4 | Jun 7, 2024 | Director |
ZLAB | Zai Lab Ltd | Jun 29, 2023 | 1 | $500K | 4 | Jun 30, 2023 | Director |
SYRS | Syros Pharmaceuticals, Inc. | Jun 1, 2023 | 2 | $0 | 4 | Jun 2, 2023 | Director |
ZLAB | Zai Lab Ltd | Dec 8, 2022 | 2 | -$278K | 4 | Dec 9, 2022 | Director |
FMTX | Forma Therapeutics Holdings, Inc. | Oct 14, 2022 | 7 | $0 | 4 | Oct 14, 2022 | Director |
SYRS | Syros Pharmaceuticals, Inc. | Sep 16, 2022 | 2 | $0 | 4 | Sep 19, 2022 | Director |
FMTX | Forma Therapeutics Holdings, Inc. | Jun 8, 2022 | 2 | $0 | 4 | Jun 9, 2022 | Director |
SYRS | Syros Pharmaceuticals, Inc. | Jun 1, 2022 | 1 | $0 | 4 | Jun 2, 2022 | Director |
ZLAB | Zai Lab Ltd | Jan 3, 2022 | 1 | $0 | 4 | Jan 4, 2022 | Director |
ZLAB | Zai Lab Ltd | Dec 8, 2021 | 1 | $285K | 4/A | Dec 12, 2022 | Director |
FMTX | Forma Therapeutics Holdings, Inc. | Jun 17, 2021 | 2 | $0 | 4 | Jun 21, 2021 | Director |
SYRS | Syros Pharmaceuticals, Inc. | Jun 8, 2021 | 1 | $0 | 4 | Jun 10, 2021 | Director |